Lv1
8 积分 2024-06-06 加入
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
1天前
待确认
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
1天前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
2天前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
2天前
已完结
Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody
12天前
已完结
HeLa cell line xenograft tumor as a suitable cervical cancer model: growth kinetic characterization and immunohistochemistry array
1个月前
已关闭
Patient-derived xenograft models: Current status, challenges, and innovations in cancer research
5个月前
已完结
A review of behavioral methods for the evaluation of cognitive performance in animal models: Current techniques and links to human cognition
6个月前
已完结
皖公网安备34019202002308
